Cystine
US-FDASourced from openFDA
GET
/api/v1/drug/cystineIndications
Sourced from openFDA- Support for immune deficiency.
Dosage & administration
Sourced from openFDASUGGESTED DOSAGE One dropper under tongue two times daily. Acute symptoms ½ dropper under tongue every 30 minutes for two hours.
Warnings & precautions
Sourced from openFDAUse only if cap seal is unbroken. As with drugs if you are pregnant or nursing a baby seek professional advice before using this product. Keep this and all medication out of the reach of children. To be used according to standard homeopathic indications.
FAERS reports
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
3 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
- 1Transplant Rejection267%
- 2Abdominal Discomfort133%
- 3Abdominal Pain133%
- 4Anhedonia133%
- 5Aortic Valve Incompetence133%
- 6Aortic Valve Sclerosis133%
- 7Asthenia133%
- 8Atrial Fibrillation133%
- 9Cardiac Aneurysm133%
- 10Cardiac Murmur133%
- 11Cardiomyopathy133%
- 12Dyskinesia133%
- 13Dyspnoea Exertional133%
- 14Economic Problem133%
- 15Electrocardiogram St-t Segment Depression133%
Literature
Recent PubMed references pinned to Cystine as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Cystine: A Key Protective Factor Against Childhood Hypo-HDL Cholesterolemia and Dyslipidemia-A Matched Case-Control Study.Nutrients · 2026 · Yu L, Yue Q, Zhu Q, et al.PMID 42196947DOI 10.3390/nu18101488
- [Selenocystine inhibits colon cancer cell growth by promoting reactive oxygen species generation to trigger oxidative damage].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2026 · Song Q, Miao Y, Feng X, et al.PMID 41887693DOI 10.12122/j.issn.1673-4254.2026.03.07
- L-Ergothioneine Attenuates Nephrolithiasis by Modulating Redox Signaling and Mitochondrial Function in Cystine and Calcium Oxalate Models.Antioxidants & redox signaling · 2026 · Mayayo-Vallverdú C, Vecino-Pérez M, Prat E, et al.PMID 41814506DOI 10.1177/15230864261431276
- Membrane-translocated SO₂/₃-PRDX3 disrupts cystine uptake and GPX4 activity: A pivotal mechanism of boron-induced renal ferroptosis in broiler.Ecotoxicology and environmental safety · 2026 · Li Y, Li Y, Guo M, et al.PMID 41775182DOI 10.1016/j.ecoenv.2026.119969
- A Refined Method for Micro-Scale Blood Cystine Measurement in Preclinical Cystinosis Models.International journal of molecular sciences · 2026 · De Leo E, Cairoli S, Rega LR, et al.PMID 41751789DOI 10.3390/ijms27041654
- Synergistic Effects in a Homochiral Metal-Organic Framework Enable Enhanced Enantiomeric Discrimination and Ultrasensitive Detection of Disulfide-Containing Biomarkers.ACS sensors · 2026 · Dong ZY, Xi FG, Li RX, et al.PMID 41747096DOI 10.1021/acssensors.5c04436
- Cystine Promotes the Development of Hair Follicle in Rabbits by Regulating Wnt Signalling Pathway.Journal of animal physiology and animal nutrition · 2026 · Liu C, Liu X, Li L, et al.PMID 41739955DOI 10.1111/jpn.70050
- A metal-free cascade nanoreactor reprograms the cystine-glutathione axis for disulfidptosis-pyroptosis therapy.Acta biomaterialia · 2026 · Yang N, Cao C, Li Y, et al.PMID 41662918DOI 10.1016/j.actbio.2026.02.011
Clinical trials
The 10 most recently updated of 31 ClinicalTrials.gov registrations naming Cystine as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- Use of Cysteamine in the Treatment of CystinosisRecruiting · Observational · 330 enrolled · National Human Genome Research Institute (NHGRI)NCT00359684updated 2026-05-29
- Efficacy and Safety of Millet Seed Extract in Telogen Effluvium TreatmentCompleted · Interventional · 60 enrolled · Kasr El Aini HospitalNCT07348120updated 2026-05-05
- Lipoic Acid Supplement for Cystine StoneCompleted · Phase 2 · Interventional · 50 enrolled · Thomas Chi, MDNCT02910531updated 2026-04-15
- Optimizing Treatment of Co-occurring Smoking and Unhealthy Alcohol Use Among PWH in Nairobi, KenyaNot yet recruiting · Phase 3 · Interventional · 300 enrolled · University of ChicagoNCT06790342updated 2025-12-11
- The Effect of Sodium-glucose Cotransporter (SGLT) 2 Inhibitors on Cystine Stone Formation: A Preliminary StudyCompleted · Phase 2 · Interventional · 10 enrolled · University of California, San FranciscoNCT04818034updated 2025-10-16
- Prandial Metabolic Phenotype in AdultsRecruiting · Interventional · 50 enrolled · Texas A&M UniversityNCT05400733updated 2025-10-01
- Mitochondrial Capacity Boost in ALS (MICABO-ALS) TrialRecruiting · Phase 2 · Interventional · 60 enrolled · Dallas VA Medical CenterNCT04244630updated 2025-08-24
- Rare Kidney Stone Consortium Patient RegistryRecruiting · Observational · 730 enrolled · Mayo ClinicNCT00588562updated 2025-07-04
- The Impact of a Nutritional Supplement (Impryl®) on Male FertilityActive not recruiting · Interventional · 1,200 enrolled · Radboud University Medical CenterNCT03337360updated 2025-04-04
- Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 VolunteersRecruiting · Interventional · 45 enrolled · Industrial Farmacéutica Cantabria, S.A.NCT06841458updated 2025-02-24
Frequently asked questions
- What is Cystine used for?
- According to FDA labeling, Cystine carries indications including: Support for immune deficiency.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
Note. Data for
cystine is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.